Cargando…
Identification of Mtb GlmU Uridyltransferase Domain Inhibitors by Ligand-Based and Structure-Based Drug Design Approaches
Targeting enzymes that play a role in the biosynthesis of the bacterial cell wall has long been a strategy for antibacterial discovery. In particular, the cell wall of Mycobacterium tuberculosis (Mtb) is a complex of three layers, one of which is Peptidoglycan, an essential component providing rigid...
Autores principales: | Singh, Manvi, Kempanna, Priya, Bharatham, Kavitha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105790/ https://www.ncbi.nlm.nih.gov/pubmed/35566155 http://dx.doi.org/10.3390/molecules27092805 |
Ejemplares similares
-
Structure of N-acetylglucosamine-1-phosphate uridyltransferase (GlmU) from Mycobacterium tuberculosis in a cubic space group
por: Verma, Sunil Kumar, et al.
Publicado: (2009) -
The Mechanism of Acetyl Transfer Catalyzed by Mycobacterium tuberculosis GlmU
por: Craggs, Peter D., et al.
Publicado: (2018) -
GlmU inhibitor from the roots of Euphorbia ebracteolata as an anti-tuberculosis agent
por: Han, Xiuyan, et al.
Publicado: (2022) -
Kinetic Modelling of GlmU Reactions – Prioritization of Reaction for Therapeutic Application
por: Singh, Vivek K., et al.
Publicado: (2012) -
A web server for predicting inhibitors against bacterial target GlmU protein
por: Singla, Deepak, et al.
Publicado: (2011)